# Mesoglycan for Acute Hemorrhoidal Disease

> **NCT06101992** · NA · UNKNOWN · sponsor: **Societa Italiana di Chirurgia ColoRettale** · enrollment: 50 (estimated)

## Conditions studied

- Hemorrhoids

## Interventions

- **DRUG:** Mesoglycan
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06101992
- **Lead sponsor:** Societa Italiana di Chirurgia ColoRettale
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06101992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06101992, "Mesoglycan for Acute Hemorrhoidal Disease". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT06101992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*